CHM

12.5%

1.8¢ chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-71

First 71 Last

Share
Profile

Follow
valueadd

5,822 Posts.

1835

06/06/24

20:33

Post #: 74202891
Share

Originally posted by pfeifer1982 ↑

You have been handed another paddle today with the first cohort now dosed. Thr company is still moving along, despite all the doom and gloom.

Imagine this was an oil mining company with 5 large parcels in different parts of the world. Each parcel so far only has had some seismic surveys done to a small part of it, with the potential of multiple wells on each parcel and each well could possibly generate peak sales of US$3b (see Celgene's estimates on JCAR017 back in 2018 as an example). If you now tell Aussie investors that each parcel is currently valued at less than A$5m if you take into account the current cash position, they would literally throw their money at this opportunity.

And here we are after more than one CR that didn't go as anticipated, with a market that loves its mining companies and banks, not willing to fork out a few cents per share in a biotech company that has preclinical and initial clinical data in some of the most aggressive types of cancer... Perhaps CHM should start digging holes in some far away parts of the world or give out loans. Until that happens, only PH is to blame... obviously, and JC, while someone reading and maybe seeding this nonsense is selling into this fear mongering. I have now almost doubled my holding over the past 7 days. Thank you.

Expand

So true !!!

and I think their might be a few more accumulating ....
why try to pick the absolute bottom ....when the absolute tope could be a couple of orders of magnitude above where we are

LOL

CHM Price at posting: 1.6¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Revolutionary inverter technology leads the clean energy charge

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Emerald & Azure score Digger & Dealer awards

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Bitcoin: Current State of Play & Where to Next | Swyftx

TNC

True North increases silver metal at QLD's Vero deposit by 20%

There are more pages in this discussion • 3 more messages in this thread...

First 71 Last

Add CHM (ASX) to my watchlist

(20min delay)
Last 1.8¢		Change 0.002(12.5%)		Mkt cap ! $15.96M

Open	High	Low	Value	Volume
1.7¢	2.0¢	1.7¢	$28.92K	1.577M

Buyers (Bids)

No.	Vol.	Price($)
1	95523	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	2523	1

View Market Depth

No.	Vol.	Price($)
3	490039	0.017
10	1253317	0.016
10	1735472	0.015
3	2575142	0.014
2	266900	0.013

Price($)	Vol.	No.
0.020	584413	9
0.021	420857	2
0.022	1423767	5
0.023	200000	2
0.024	400000	3

Last trade - 16.10pm 09/08/2024 (20 minute delay)

CHM (ASX) Chart

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-71

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Revolutionary inverter technology leads the clean energy charge

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Emerald & Azure score Digger & Dealer awards

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Bitcoin: Current State of Play & Where to Next | Swyftx

True North increases silver metal at QLD's Vero deposit by 20%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-71

Top Stories

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Revolutionary inverter technology leads the clean energy charge

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Emerald & Azure score Digger & Dealer awards

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Bitcoin: Current State of Play & Where to Next | Swyftx

True North increases silver metal at QLD's Vero deposit by 20%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News